Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vytorin vs Standard Statins in Dyslipidemia
NCT01587235Phase 4Withdrawn
- Sponsor
- Organon & Co.
- Start
- Mar 2013
- Primary completion
- May 2014
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 4 trial of Vytorin in dyslipidemia, sponsored by Organon & Co.. Planned start Mar 2013; status: withdrawn.
02
Drugs
Vytorin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01587235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587235.